Literature DB >> 18850478

The role of biomarkers in the early detection of anthracycline-induced cardiotoxicity in children: a review of the literature.

Annelies M C Mavinkurve-Groothuis1, Livia Kapusta, Amiram Nir, Jacqueline Groot-Loonen.   

Abstract

Anthracycline-induced cardiotoxicity can cause serious health problems for an increasing number of children surviving childhood malignancies. Early detection of cardiac failure is critically important for the prevention and management of anthracycline-induced cardiotoxicity. The aim of this research was to determine the role of biomarkers in the early detection of anthracycline-induced cardiotoxicity in children. A literature review is presented of studies regarding the use of the biomarkers B-type natriuretic peptide (BNP), N-terminal pro-BNP (NT-pro-BNP), cardiac troponin T (cTnT), and cardiac troponin I (cTnI) in relation with anthracycline-induced cardiotoxicity in children. Six of 14 studies in children showed a significant relation between elevated biomarkers BNP, NT-pro-BNP, and cTnT and cardiac dysfunction. Six studies, although small, suggest that BNP, NT-pro-BNP, and cTnT might be useful markers in the early detection of anthracycline-induced cardiotoxicity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18850478     DOI: 10.1080/08880010802244001

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  19 in total

Review 1.  Cardiovascular Complications of Cancer Therapy: Best Practices in Diagnosis, Prevention, and Management: Part 1.

Authors:  Hui-Ming Chang; Rohit Moudgil; Tiziano Scarabelli; Tochukwu M Okwuosa; Edward T H Yeh
Journal:  J Am Coll Cardiol       Date:  2017-11-14       Impact factor: 24.094

Review 2.  Pediatric Cardio-Oncology: Development of Cancer Treatment-Related Cardiotoxicity and the Therapeutic Approach to Affected Patients.

Authors:  Thomas D Ryan; Rajaram Nagarajan; Justin Godown
Journal:  Curr Treat Options Oncol       Date:  2019-05-25

Review 3.  Biomarkers in cancer therapy related cardiac dysfunction (CTRCD).

Authors:  Rohit Moudgil; Parag A Parekh
Journal:  Heart Fail Rev       Date:  2018-03       Impact factor: 4.214

4.  What Is High Enough? Elevated NT-pro-BNP in Decompensated Paroxysmal Supraventricular Tachycardia.

Authors:  Shawn Reeves; Clayton Womack; L O Lutherer; Christopher Todd; Kerrie Pinkney; Thivakorn Kasemsri
Journal:  J Pediatr Intensive Care       Date:  2017-06-12

5.  Pharmacokinetic-pharmacodynamic modelling of acute N-terminal pro B-type natriuretic peptide after doxorubicin infusion in breast cancer.

Authors:  Shuang Liang; Richard C Brundage; Pamala A Jacobson; Anne Blaes; Mark N Kirstein
Journal:  Br J Clin Pharmacol       Date:  2016-06-03       Impact factor: 4.335

6.  Myocardial performance index and biochemical markers for early detection of doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukaemia.

Authors:  Antonio Ruggiero; Gabriella De Rosa; Daniela Rizzo; Andrea Leo; Palma Maurizi; Alessia De Nisco; Francesca Vendittelli; Cecilia Zuppi; Alvaro Mordente; Riccardo Riccardi
Journal:  Int J Clin Oncol       Date:  2012-08-22       Impact factor: 3.402

Review 7.  Educational paper: decreasing the burden of cardiovascular disease in childhood cancer survivors: an update for the pediatrician.

Authors:  Rejane F Dillenburg; Paul Nathan; Luc Mertens
Journal:  Eur J Pediatr       Date:  2013-01-30       Impact factor: 3.183

Review 8.  Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection.

Authors:  Martin Stěrba; Olga Popelová; Anna Vávrová; Eduard Jirkovský; Petra Kovaříková; Vladimír Geršl; Tomáš Simůnek
Journal:  Antioxid Redox Signal       Date:  2012-10-12       Impact factor: 8.401

9.  Review of cardiotoxicity in pediatric cancer patients: during and after therapy.

Authors:  Joy M Fulbright
Journal:  Cardiol Res Pract       Date:  2011-05-23       Impact factor: 1.866

10.  BNP predicts chemotherapy-related cardiotoxicity and death: comparison with gated equilibrium radionuclide ventriculography.

Authors:  Dorthe Skovgaard; Philip Hasbak; Andreas Kjaer
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.